Dr. Adam Rosendorf initially believed that Theranos would be the “next Apple,” he testified to the jury on Friday. However, more than a year after joining the company in April 2013, inconsistent blood test results were constantly flowing, and I felt his sincerity. He said he was ready to publish everything.
“I’ve come to believe that the company is more interested in public relations and financing than patient care,” Rosendorff told the jury. “I wanted to protect myself, and I wanted to let Theranos know what was going on.”
A former medical director of the Clinical Research Institute at Pittsburgh Children’s Hospital came to federal court on the seventh day of the trial against Holmes, who was acquitted of transfer fraud and conspiracy to commit transfer fraud, as the fourth witness of the prosecution. I did. Rosendorf was the man who had the medical expertise to know how a functioning laboratory was operated, claimed by US Federal Attorney-at-Law Robert Reach.
Rosendorf said he was sold with Holmes’ idea of doing a blood test with the smallest possible sample after meeting her and then Theranos president Ramesh “Sunny” Balwani in San Francisco.
Like the experience of a former lab assistant Erica Chan said Rosendorf said in court on September 15 that he soon learned that Theranos had ordered the modification of third-party blood testing equipment, including competing tech health giant Siemens.